Summary Epidermal growth factor (EGF). its related peptide transforming growth factor (TGF-a) and their common receptor (EGFR) have been implicated in the control of cell proliferation and differentiation in the gastrointestinal epithelium and may play an important role in gastric carcinogenesis. We compared the immunohistochemical expression and topographic distribution of these peptides using Western blot analysis in gastric carcinoma precursor lesions and in non-cancer tissue. We observed: (i) increased and extended expression of TGF-a in normal mucosa and hyperplasia in carcinoma fields compared 'with non-cancer controls: (ii) increased expression of EGFR in intestinal metaplasia (IM) from carcinoma fields compared with controls; (iii) EGF expression was not detected in normal mucosa and only weakly in IM; (iv) coexpression of TGF-a EGFR and EGF EGFR was higher in intestinal metaplasia in carcinoma fields than in non-cancer controls. We conclude that altered expression of TGF-a EGFR is associated with morphological changes dunrng gastric carcinogenesis. In this regard increased expression of TGF-a is a very early event which is subsequently followed by up-regulation of EGFR and this has important biological and clinical implications.
Gastric carcinogenesis is a stepwise process which starts with molecular changes in normal cells resulting in phenotypic adaptation. In this regard chronic gastritis is one of the earliest identifiable histological abnormalities and may lead to intestinal metaplasia (IM), dysplasia and ultimately adenocarcinoma (Correa, 1988) . The underlying mechanisms that control this process are not as yet fully understood. The majority of gastric carcinomas appear to be caused by environmental factors resulting in mucosal damage and repair (Parsonnet et al., 1991 ; UK Subgroup of the ECPEuronut-IM Study Group, 1992; Pignatelli et al., 1993) . This pleomorphic response is regulated in part by inhibitory and stimulatory molecules derived from proto-oncogenes and tumour-suppressor genes (Tahara, 1993) . Growth factors are important regulators of cell differentiation and proliferation and play an important role in maintaining the integnty of the epithelium. Increased expression in cells or aberrant topographical distribution of the growth-regulatory peptides epidermal growth factor (EGF) and transforming growth factor X (TGF-uc) and their receptor (EGFR) has been described in the gastrointestinal epithelium associated with mitogenesis and carcinogenesis (Goodlad and Wright, 1990; Jankowski. 1992; Nasim et al.. 1992; Filipe and Jankowski, 1993) . Human TGF-a has been mapped to chromosome 2 to the short arm region 2pll -2pl3. and it is known that chromosome 2 contains other genes that are involved in growth regulation and tumorigenesis. EGFR has been found to be overexpressed at high frequency in a wide range of tumours. Increased expression of TGF-x is frequent in gastric carcinoma (60% ). particularly the intestinal type of carcinoma, but EGFR overexpression was less frequent (18%) in our series (Goodlad and Wright. 1990; Jain et al., 1991; Lemoine et al.. 1991) . Coexpression of EGF and its receptor (EGFR) is correlated with progression of these tumours and poor prognosis (Yonemura et al.. 1991 (Yonemura et al.. . 1992 The purpose of this study was to assess the altered expression of growth factors EGF and TGF-x and their common receptor EGFR in the precursor lesions to gastric carcinoma and the possible role of such altered expression in the multistep process of malignancy. In addition. we were interested in assessing whether immunoreactivity to growth factors and their receptors corresponded with normal-or aberrant-sized protein products by Western blot analysis.
Materials and methods
Formalin-fixed paraffin-embedded samples from 16 stomachs resected for early stage TI gastric carcinoma and nine from advanced gastnrc carcinomas were available: 19 intestinal, 4 diffuse and two mixed (Lauren, 1965) . Non cancer control biopsies were obtained from gastric ulcer or chronic gastritis patients (n = 56). The non-carcinoma control samples included specimens of normal histology (n = 41) and intestinal metaplasia (n = 15).
Carcinoma field changes from the 16 TI gastric carcinomas included histologically normal mucosa (n = 16). hyperplasia (n = 14), intestinal metaplasia (n = 17) and dysplasia (n = 10. of which seven cases were high grade) (Riddel et al.. 1983) .
Carcinoma field changes from the nine advanced gastric carcinomas included histologically normal mucosa (n = 7), hyperplasia (n = 3), intestinal metaplasia (n = 5) and dysplasia (n = 4, of which two cases were high grade). Western blot analysis Proteins were extracted from fresh-frozen specimens, including normal mucosa (n = 3). intestinal metaplasia (n = 3) and well or moderately/poorly differentiated gastric carcinomas (n = 4). Samples were homogenised in sodium dodecyl sulphate, glycine,Tris gel loading buffer in the presence of a protease inhibitor for 2 mmn. After centrifugation at 30 000 g for 20 min, the resultant supernatant was frozen. The protein concentration was estimated by light spectrophotometry at 595 nm according to the Bradford method (Jankowski, 1994a) .
Prior to running the proteins in a 15% acrylamide gel (7.5% gel was used for EGFR) at low voltage (8 V cm-'), P-mercaptoethanol was added to the samples and these were heated at 100°C for 3 min. (Tables III and MV ). In the majority of normal mucosas from non-cancer control biopsies, TGF-x immunoreactivity was confined to the upper gland compartment (95%) compared with only 22% of normal mucosas in carcinoma fields (Figures 1 and 2) . None of the normal control biopsies expressed TGF-x throughout the whole glandular epithelium compared with 77% of 'normal' mucosa from carcinoma fields. These differences between distnrbution of TGF-a in the upper gland compartment are less marked for intestinal metaplasia, being 64% and 77% in IM in carcinoma field lesions and IM non-cancer controls respectively. Most dysplastic lesions had further reductions in TGF-a in the upper gland compartment (58%).
The positional patterns of EGFR expression are similar to but more marked than those revealed with TGF-a. In particular, an extensive EGFR expression throughout the whole glandular epithelium is seen in intestinal metaplasia in carcinoma fields (80%) compared with controls (50%) (Figures  3 and 4) . In addition, the intensity of EGFR expression increases serially in normal gastric mucosa from controls to normal in gastric cancer fields. intestinal metaplasia and intestinal metaplasia from carcinoma stomachs and to dysplasia. In this regard a specimen of dysplastic mucosa with IM showed markedly increased EGFR expression ( Figure  5 ).
EGF was not immunohistochemically detectable in normal mucosa but was weakly detectable in intestinal metaplasia.
Coexpression High levels of TGF-m/EGFR coexpression were observed in the precursor lesions with the exception of hyperplasia. In particular, the median intensity of immunoreactivity was twice as high in normal mucosa from carcinoma fields as in non-cancer controls, but no difference was detected in intestinal metaplasia. Conversely, in the few speci- Western blot analysis EGF immunoreactivity corresponded with molecular weight species of 6 kDa, however larger molecular weight bands were also present at 9, 14 and 18 kDa. This may indicate a common epitope of the EGF antibody with EGF and its precursors or other related members of the EGF family ( Figure 6 ). TGF-x immunoreactivity was strongest at 6 kDa ( Figure  7 ). It is also evident that the signet ring carcinoma has reduced immunoreactivity compared with the welldifferentiated carcinomas and the intestinal metaplasia. In addition, a competition reaction was performed in which prior incubation of TGF-x (TGF-a 50 amino acid peptide, Sigma, UK) markedly reduced the subsequent immunoreactivity in the Western blot compared with unblocked paired specimens (Figure 8) .
EGFR immunoreactivity was maximal at 170 kDa, indicating specificity for the mature receptor (Figure 9 ).
Expression of EGF, TGF-x and EGFR Our data support the hypothesis that increased EGFR and TGF-a expression is associated with early events in gastric (Di Marco et al., 1990; Jankowski, 1994b (Rokkas et al.. 1991; Filipe et al., 1993 Filipe et al., , 1994 (Di Marco et al., 1990; Tahara, 1990; Jankowski, 1994b 1990 Martin et al., 1992; Tohdo et al., 1993; Brito et al., 1994; Jankowski, 1994b) . Overexpression of Tpr-met RNA has been detected in the earliest stage of superficial gastritis with hyperplasia and is also present with variable intensity in the various stages of progression to carcinoma, suggesting the possible involvement of this oncogene in gastric tumorigenesis (Soman et al., 1991) .
Moreover, crypto, a gene of the EGF family, is overexpressed in intestinal metaplasia as well as in welldifferentiated adenocarcinoma. Also of interest is that the 2.2 kb mRNA is detected in almost all intestinal metaplasias and well-differentiated adenocarcinomas (Tahara, 1993 (iii) + TGF-a and EGFR with dysplasia.
(iv) + c-erbB2 with generation of invasive neoplasia.
(v) t EGF with advanced neoplasia and metastases.
